Output details
1 - Clinical Medicine
University of Oxford
Return to search
Output 0 of 0 in the submission
Article title
Golimumab, a new human anti-tumor necrosis factor alpha antibody, administered intravenously in patients with active rheumatoid arthritis: Forty-eight-week efficacy and safety results of a phase III randomized, double-blind, placebo-controlled study.
Type
D - Journal article
Title of journal
Arthritis Rheum
Article number
-
Volume number
62
Issue number
4
First page of article
917
ISSN of journal
0004-3591
Year of publication
2010
URL
-
Number of additional authors
7
Additional information
-
Interdisciplinary
-
Cross-referral requested
-
Research group
J - (MSD) Musculoskeletal Diseases
Citation count
41
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-